Borja Mora‐Peris

1.6k total citations
20 papers, 139 citations indexed

About

Borja Mora‐Peris is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Borja Mora‐Peris has authored 20 papers receiving a total of 139 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in Borja Mora‐Peris's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). Borja Mora‐Peris is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). Borja Mora‐Peris collaborates with scholars based in United Kingdom, Spain and United States. Borja Mora‐Peris's co-authors include Alan Winston, Jaime H. Vera, Saye Khoo, Laura Else, Jonathan Underwood, D.J. Back, Lucy Garvey, Steve Kaye, N Mackie and Adam Waldman and has published in prestigious journals such as AIDS, Journal of Antimicrobial Chemotherapy and British Journal of Clinical Pharmacology.

In The Last Decade

Borja Mora‐Peris

18 papers receiving 137 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Borja Mora‐Peris United Kingdom 9 83 72 36 28 15 20 139
Kathy Ton United States 3 40 0.5× 63 0.9× 11 0.3× 20 0.7× 19 1.3× 5 95
Javier Rodríguez-Centeno Spain 9 101 1.2× 80 1.1× 108 3.0× 82 2.9× 61 4.1× 17 230
Hanna Mar United States 5 92 1.1× 52 0.7× 46 1.3× 23 0.8× 9 0.6× 10 141
Jerry Cade United States 3 37 0.4× 48 0.7× 11 0.3× 58 2.1× 10 0.7× 5 108
A Felici Italy 5 136 1.6× 187 2.6× 70 1.9× 94 3.4× 7 0.5× 11 325
Lynn Smiley United States 6 102 1.2× 70 1.0× 24 0.7× 49 1.8× 24 1.6× 9 210
S. Greffe France 5 25 0.3× 36 0.5× 18 0.5× 28 1.0× 16 1.1× 13 90
Hannah Walsh United States 7 18 0.2× 34 0.5× 7 0.2× 22 0.8× 15 1.0× 14 117
Gladys Sepúlveda United States 10 214 2.6× 254 3.5× 58 1.6× 40 1.4× 25 1.7× 12 341
Tariq Ahmad United Kingdom 3 17 0.2× 27 0.4× 14 0.4× 12 0.4× 33 2.2× 5 97

Countries citing papers authored by Borja Mora‐Peris

Since Specialization
Citations

This map shows the geographic impact of Borja Mora‐Peris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Borja Mora‐Peris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Borja Mora‐Peris more than expected).

Fields of papers citing papers by Borja Mora‐Peris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Borja Mora‐Peris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Borja Mora‐Peris. The network helps show where Borja Mora‐Peris may publish in the future.

Co-authorship network of co-authors of Borja Mora‐Peris

This figure shows the co-authorship network connecting the top 25 collaborators of Borja Mora‐Peris. A scholar is included among the top collaborators of Borja Mora‐Peris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Borja Mora‐Peris. Borja Mora‐Peris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milinkovic, Ana, Borja Mora‐Peris, Dana Ogaz, et al.. (2025). HIV seroconversions and genotypic viral resistance profiles in the PrEP impact trial. HIV Medicine. 26(8). 1300–1303.
2.
Sweni, Shah, Alessia Dalla Pria, Borja Mora‐Peris, et al.. (2025). Dolutegravir with enteral feeds in intensive care: Case series with therapeutic drug monitoring. British Journal of Clinical Pharmacology. 91(11). 3272–3278.
3.
Khan, Maryam, Daniel Bradshaw, Colin Brown, et al.. (2023). Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays. Open Forum Infectious Diseases. 10(5). ofad108–ofad108. 1 indexed citations
4.
Abbara, Aula, et al.. (2023). Parvovirus B19 induced acute severe anaemia in a well-controlled HIV-positive individual. Clinical Infection in Practice. 21. 100334–100334. 2 indexed citations
5.
Barnacle, James, Malick M. Gibani, Ravi Mehta, et al.. (2022). The clinical presentation of monkeypox: a retrospective case-control study of patients with possible or probable monkeypox in a West London cohort. International Journal of Infectious Diseases. 126. 48–53. 14 indexed citations
6.
Toniolo, Sofia, Mara Cercignani, Borja Mora‐Peris, et al.. (2020). Changes in functional connectivity in people with HIV switching antiretroviral therapy. Journal of NeuroVirology. 26(5). 754–763. 8 indexed citations
7.
Mora‐Peris, Borja, et al.. (2019). Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitis. BMJ Case Reports. 12(2). e227916–e227916. 7 indexed citations
8.
Mora‐Peris, Borja, George Bouliotis, Ranjababu Kulasegaram, et al.. (2018). Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals. AIDS. 32(8). 1007–1015. 8 indexed citations
9.
Scott, Joseph C., Jonathan Underwood, Lucy Garvey, Borja Mora‐Peris, & Alan Winston. (2016). A comparison of two post-processing analysis methods to quantify cerebral metabolites measuredviaproton magnetic resonance spectroscopy in HIV disease. British Journal of Radiology. 89(1060). 20150979–20150979. 9 indexed citations
10.
Mora‐Peris, Borja, Elizabeth Stevens, Francesca Ferretti, et al.. (2016). Evolution of changes in cognitive function after the initiation of antiretroviral therapy. AIDS Research and Therapy. 13(1). 20–20. 8 indexed citations
11.
Mora‐Peris, Borja, Alan Winston, Lucy Garvey, et al.. (2015). HIV-1 CNSin vitroinfectivity models based on clinical CSF samples. Journal of Antimicrobial Chemotherapy. 71(1). 235–243. 5 indexed citations
12.
Mora‐Peris, Borja, Laura Else, David Goldmeier, et al.. (2015). A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers. Journal of Antimicrobial Chemotherapy. 70(6). 1812–1815. 2 indexed citations
13.
Vera, Jaime H., Akil Jackson, Laura Dickinson, et al.. (2015). The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age. HIV Clinical Trials. 16(1). 39–42. 10 indexed citations
14.
Mora‐Peris, Borja, Victoria Watson, Jaime H. Vera, et al.. (2014). Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 69(6). 1642–1647. 27 indexed citations
15.
Mora‐Peris, Borja, Adam Croucher, Laura Else, et al.. (2013). Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects. Journal of Antimicrobial Chemotherapy. 68(6). 1348–1353. 11 indexed citations
16.
Mora‐Peris, Borja, N Mackie, Dan Suan, et al.. (2013). Raltegravir resistance in the cerebrospinal fluid. Infection. 41(3). 731–734. 2 indexed citations
17.
Mora‐Peris, Borja, et al.. (2012). Pharmacokinetic profile of maraviroc 150 mg dosed with darunavir/ritonavir once daily, with and without nucleoside analogues, in HIV‐infected subjects. Journal of the International AIDS Society. 15(S4). 1–2. 1 indexed citations
18.
Mora‐Peris, Borja, et al.. (2010). Medical Eponyms. Archives of Internal Medicine. 170(16). 1499–500. 16 indexed citations
19.
Mora‐Peris, Borja, Félix García, Francisco Ruíz, et al.. (2008). JISBD2007-08: Software generic measurement framework based on MDA. IEEE Latin America Transactions. 3 indexed citations
20.
Mestre, Gabriel, Felipe García, Estebán Martínez, et al.. (2008). Short Communication: Natural Killer Cells and Expression of KIR Receptors in Chronic HIV Type 1-Infected Patients after Different Strategies of Structured Therapy Interruption. AIDS Research and Human Retroviruses. 24(12). 1485–1495. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathy Ton Breakdown of academic impact, for papers by Javier Rodríguez-Centeno Breakdown of academic impact, for papers by Hanna Mar Breakdown of academic impact, for papers by Jerry Cade Breakdown of academic impact, for papers by A Felici Breakdown of academic impact, for papers by Lynn Smiley Breakdown of academic impact, for papers by S. Greffe Breakdown of academic impact, for papers by Hannah Walsh Breakdown of academic impact, for papers by Gladys Sepúlveda Breakdown of academic impact, for papers by Tariq Ahmad
Rankless by CCL
2026